Ventex

Ventex appears to be an active private company positioned as a nanobio and healing-technology developer rather than a traditional therapeutics biotech. Publicly available business descriptions characterize it as developing healing and assistance technologies intended to support human, environmental, and nature-related wellbeing, and note that it restructured in 2019 into a nano-bio company. Based on the limited accessible information, Ventex does not appear to have a conventional disclosed drug-development pipeline with named assets, molecular targets, or clinical-stage programs. Instead, it seems to operate as a technology-oriented healthcare or wellness company built around a broader platform approach. The available public record is sparse, so many standard biotech fields such as trial stage, named products, and partnerships cannot be confirmed.